Third BNT162b2 dose elicits more durable immune response than second dose - News-Medical.Net

5/9/2022 12:00:00 AM2 years 11 months ago

Researchers evaluated the durability of immune responses post-third dose of the BNT162b2 vaccine against SARS-CoV-2.

In a recent study posted to the medRxiv* preprint server, researchers evaluated the durability of immune responses post-third dose of the BNT162b2 vaccine. Study: Durability of the immune response t… [+6244 chars]

full article...